Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery
Sang Joon Lee,1,* Young-Il Jeong,2,* Hyung-Kyu Park,3 Dae Hwan Kang,2,4 Jong-Suk Oh,3 Sam-Gyu Lee,5 Hyun Chul Lee31Department of Biomedical Sciences, Chonnam National University Medical School, Gwangju, 2Biomedical Research Institute, Pusan National University Hospital, Busan, 3Department of Microbi...
Main Authors: | Lee SJ, Jeong YI, Park HK, Kang DH, Oh JS, Lee SG, Lee HC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-08-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/enzyme-responsive-doxorubicin-release-from-dendrimer-nanoparticles-for-peer-reviewed-article-IJN |
Similar Items
-
Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity
by: Alimoradi H, et al.
Published: (2018-11-01) -
Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery
by: György Babos, et al.
Published: (2020-10-01) -
Design and Synthesis of Doxorubicin Conjugated Gold Nanoparticles as Anticancer Drug Delivery System
by: Xia, Long
Published: (2017) -
Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.
by: Sibu P Kuruvilla, et al.
Published: (2017-01-01) -
DENDRIMERS IN ANTICANCER TARGETED DRUG DELIVERY: ACCOMPLISHMENTS, CHALLENGES AND DIRECTIONS FOR FUTURE
by: A. M. Amjad
Published: (2021-06-01)